Genmab A/S (GNMSF) FCF Margin (2018 - 2026)
Genmab A's (GNMSF) quarterly FCF Margin came in at 0.33% in Q1 2026, down 3981.0% YoY from 0.01% in Q1 2025, and down 98.99% on a QoQ basis from 33.25% in Q3 2025.
Genmab A/S (GNMSF) FCF Margin (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 6 years of FCF Margin data on file, last reported at 0.33% in Q1 2026.
- Quarterly FCF Margin fell 3981.0% year-over-year to 0.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.55% (down 914.0% YoY) and the FY2025 annual result came in at 162.07%, down 19728.0% from the prior year.
- FCF Margin declined to 0.33% in Q1 2026, from 33.25% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 40.14% in Q1 2025 to a low of 0.33% in Q1 2026.
- A 3-year average of 27.8% and a median of 33.25% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2025 — FCF Margin surged 382 bps — and 2026, when it slumped 3981 bps.
- Tracing GNMSF's FCF Margin over 3 years: stood at 33.53% in 2024, then declined by 1 bps to 33.25% in 2025, then tumbled by 99 bps to 0.33% in 2026.
- The last three FCF Margin figures came in at 0.33% (Q1 2026), 33.25% (Q3 2025), and 19.94% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.19% |
| Mar 31, 2026 | 0.33% |
| Sep 30, 2025 | 33.25% |
| Jun 30, 2025 | 19.94% |
| Mar 31, 2025 | 40.14% |
| Sep 30, 2024 | 33.53% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 36.32% |
| Sep 30, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 30,684,218,017,317.98% |
| Dec 31, 2018 | 35.37% |